10-Q · August 4, 2026
BlueLinx delivered improved Q2 operating performance, with revenue up 4.4% to $814.077 million, gross margin up 190 basis points to 17.2%, and GAAP diluted EPS up to $0.81 from $0.54 a year earlier. Both specialty and…
Earnings analysis · 10-Q
Filed November 3, 2026 · Our reading of the company's report
The latest report
BlueLinx delivered strong year-over-year revenue and margin growth, with revenue of $812.610 million up 8.5% and gross margin improving to 16.1%. However, GAAP diluted EPS was a $0.07 loss versus the $0.60 estimate,…
BlueLinx delivered strong year-over-year revenue and margin growth, with revenue of $812.610 million up 8.5% and gross margin improving to 16.1%. However, GAAP diluted EPS was a $0.07 loss versus the $0.60 estimate, creating a meaningful divergence from adjusted diluted EPS of $0.68. Management expects slightly lower Q4 daily sales volumes, while providing category-level margin expectations but no revenue or EPS guidance. Overall sentiment is neutral because operational improvements were offset by the GAAP earnings miss and softer volume outlook.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Revenue was $812.610 million, up 8.5% year over year, although it was slightly below the $814.170 million consensus estimate.
Gross margin expanded to 16.1%, compared with 14.4% in Q3 2025, a 1.7 percentage-point improvement.
Adjusted diluted EPS was $0.68 and adjusted EBITDA increased 42% to $31.709 million, indicating stronger underlying profitability despite the GAAP loss.
Both product categories strengthened year over year, while Q4 specialty and structural gross-margin expectations were 17.5%-18.5% and 9.0%-10.0%, respectively.
GAAP diluted EPS was a loss of $0.07 versus the $0.60 consensus estimate, a $0.67 per-share shortfall and a deterioration from $0.20 in Q3 2025.
Average daily sales volumes for Q4 2026 are expected to be slightly below both Q4 2025 and Q3 2026, signaling near-term volume pressure despite year-to-date revenue growth.
Q4 structural gross margin is expected at 9.0%-10.0%, materially below the specialty gross-margin outlook of 17.5%-18.5%, leaving consolidated profitability exposed to product mix.
The company disclosed that 1,959 shares were withheld during the quarter for employee tax obligations, while no shares were repurchased under the public programs; approximately $3.7 million remained under the 2023 authorization as of October 3, 2026.
No quantitative revenue or EPS guidance was provided. For Q4 2026, specialty gross margin is expected at 17.5%-18.5%, structural gross margin at 9.0%-10.0%, and average daily sales volumes are expected to be slightly below Q4 2025 and Q3 2026. The filing states there were no material changes to market-risk exposure from the 2025 Form 10-K and no material changes to previously disclosed risk factors.
BlueLinx delivered improved Q2 operating performance, with revenue up 4.4% to $814.077 million, gross margin up 190 basis points to 17.2%, and GAAP diluted EPS up to $0.81 from $0.54 a year earlier. Both specialty and…
BlueLinx Holdings Inc. reported Q1 2026 results with a revenue increase to $731 million, surpassing estimates of $712.7 million, and an EPS of $0.21, significantly higher than the forecasted loss of $0.72. The increase…
BlueLinx reported essentially flat full-year net sales of $2,954.0 million in fiscal 2025 (53 weeks) versus $2,952.5 million in fiscal 2024, while profitability deteriorated: gross profit fell to $451.6 million (gross…
BlueLinx reported Q3 net sales of $748.87M and diluted EPS of $0.20 for the three months ended September 27, 2025. Revenue was essentially flat year-over-year while gross margin and operating income contracted…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.